← Eichor
Condition: Raynaud Phenomenon Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Raynaud Phenomenon

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

POLish Registry of CArdioneuroablation and CArdioneuromodulation
Phase N/A · 1 location(s) · SABAMED Medical Center Ltd. · NCT07196397Open Label Treprostinil Raynaud's Study
Phase 4 · 2 location(s) · Brigham and Women's Hospital · NCT07112183Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk
Phase 2/Phase 3 · 11 location(s) · University Hospital, Bordeaux · NCT05098704Botulinum Toxin in Raynaud's Phenomenon
Phase 4 · 1 location(s) · Emory University · NCT05125029The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
NA · 4 location(s) · Robyn T. Domsic, MD, MPH · NCT06675344
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.